Marasco, G.; Poggioli, F.; Colecchia, A.; Cabibbo, G.; Pelizzaro, F.; Giannini, E.G.; Marinelli, S.; Rapaccini, G.L.; Caturelli, E.; Di Marco, M.;
et al. A Nomogram-Based Prognostic Model for Advanced Hepatocellular Carcinoma Patients Treated with Sorafenib: A Multicenter Study. Cancers 2021, 13, 2677.
https://doi.org/10.3390/cancers13112677
AMA Style
Marasco G, Poggioli F, Colecchia A, Cabibbo G, Pelizzaro F, Giannini EG, Marinelli S, Rapaccini GL, Caturelli E, Di Marco M,
et al. A Nomogram-Based Prognostic Model for Advanced Hepatocellular Carcinoma Patients Treated with Sorafenib: A Multicenter Study. Cancers. 2021; 13(11):2677.
https://doi.org/10.3390/cancers13112677
Chicago/Turabian Style
Marasco, Giovanni, Francesco Poggioli, Antonio Colecchia, Giuseppe Cabibbo, Filippo Pelizzaro, Edoardo Giovanni Giannini, Sara Marinelli, Gian Ludovico Rapaccini, Eugenio Caturelli, Mariella Di Marco,
and et al. 2021. "A Nomogram-Based Prognostic Model for Advanced Hepatocellular Carcinoma Patients Treated with Sorafenib: A Multicenter Study" Cancers 13, no. 11: 2677.
https://doi.org/10.3390/cancers13112677
APA Style
Marasco, G., Poggioli, F., Colecchia, A., Cabibbo, G., Pelizzaro, F., Giannini, E. G., Marinelli, S., Rapaccini, G. L., Caturelli, E., Di Marco, M., Biasini, E., Marra, F., Morisco, F., Foschi, F. G., Zoli, M., Gasbarrini, A., Svegliati Baroni, G., Masotto, A., Sacco, R.,
... on behalf of the Italian Liver Cancer (ITA.LI.CA.) Group.
(2021). A Nomogram-Based Prognostic Model for Advanced Hepatocellular Carcinoma Patients Treated with Sorafenib: A Multicenter Study. Cancers, 13(11), 2677.
https://doi.org/10.3390/cancers13112677